References
- Benesch R., Benesch R., Renthal R., Maeda N. Affinity labelling of the polyphosphate binding site of hemoglobin. Biochem. 1972; 11: 3576–3582
- De Venuto F. Evaluation of human and bovine modified-hemoglobin solution as an oxygen-carrying fluid for blood volume replacement. Biomat. Art. Cels Art. Org. 1988; 16: 77–83
- Sanders K., Ackers G., Sligar S. Engineering and design of blood substitutes. Current Opinion in Structural Biology 1996; 6: 534–540
- Relihan M., Litwin M. Effect of stroma-free hemoglobin solution on clearance rate and renal function. Surgery 1972; 71(3)395–399
- Feola M., Simoni J., Tran R., Canizaro P. Mechanism of toxicity of hemoglobin solutions. Biomat. Art. Cells Art. Org. 1989; 16(1-3)217–226
- Chang T. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview. Biomat. Artif. Cells & Immob. Biotech. 1992; 20(2-4)159–179
- Nucci M., Shorr R., Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Del. Rev. 1993; 6: 133–151
- Conover C, Linberg R., Gilbert C., Shum K., Shorr R. Effect of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in both top-load and exchange transfusion rat models. Art. Organs 1997; 21: 1066–1075
- Conover C., Gilbert C., Shum K., Shorr R. The impact of polyethylene glycol (PEG) conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Art. Organs 1997; 21: 369–378
- Conover C., Lejeune L., Shum K., Gilbert C., Shorr R. Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion. Art. Organs 1997; 21: 369–378
- Conover C., Malatesta P., Lejeune L., Chang C., Shorr R. The effects of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Inv. Med. 1996; 44: 238–246
- Song D., Olano M., Wilson D., Pastusko A., Tammela O., Nho K., Shorr R. Comparison of the efficacy of blood and PEG-hemoglobin in recovery of newborn piglets from hemorrhagic hypotension: Effect on blood pressure, cortical extracellular oxygen and dopamine in the brain. Transfusion 1995; 35: 552–558
- Nho K., Zalipsky S., Abuchowski A., Davis F. PEG-modified hemoglobin as an effective oxygen carrier. Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Harris JM. Plenum Press, New-York 1992; 171–182
- Nho K., Zalipsky S., Davis F. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood substitute. 1993, U.S. Patent # 5,234,903
- Manning J. M. Influence of ligation state and concentration of hemoglobin A on its cross-linking by glycolaldehyde: Functional properties of cross-linked, carboxymethylated hemoglobin. Biochemistry 1988; 27: 6640–6644
- Rausch C. W., Feola Extra M. Pure semi-synthetic blood substitute. 1992, U.S. Patent #5,084,558
- Rumsey W., Vanderkooi J., Wilson D. Imaging of phosphorescence: A novel method for measuring oxygen distribution in perfused tissue. Science 1988; 241: 1649–51
- Wilson D., Cerniglia D. Localizaton of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res. 1992; 52: 3988–93
- Essentials of Experimental Surgery, J. Lumley, C. Green, C. Lear, J. Angell-James. Butterworth, Boston 1989
- Conover C., Linberg R., Lejeune L., Gilbert C., Shum K., Shorr R. Evaluation of the oxygen delivery ability of PEG-Hemoglobin in Sprague-Dawley rats during hemodilution. Art. Cells, Blood Subs., and Immob. Biotech., In press
- Anderson M., Mouritzer C., Gabrielli E. Mechanisms of plasma hemoglobin clearance and selective deposition in the liver and kidney: Serum haptoglobin levels and selective deposition in the liver and kidney. Ann. Surg. 1966; 64: 905–912
- Hess J., Macdonald V., Gomez C., Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif. Cells Blood Subst. Immob. Biotech. 1994; 22(3)361–372
- Migita R., Gonzales A., Gonzales M., Vandegriff K., Winslow R. Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J. Appl. Physiol. 1997; 82: 1995–2002
- Kosara H., Uozumi M., Tyuma I. The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Rad. Biol. Med. 1989; 7: 653–658
- Kim W., Greenburg A. Hemoglobin mediated vasoactivity in isolated vascular rings. Art. Cells, Blood Subs., and Immob. Biotech. 1995; 23(3)303–309
- Hart J., Ledvina M., Muldoon S. Actions of diaspirin crosslinked hemoglobin on isolated rat and dog vessels. J Lab. Clin. Med. 1997; 129: 356–363
- Vandegriff K., Winslow R. A theoretical analysis of oxygen transport: a new strategy for the design of hemoglobin based red cell substitutes. Blood substitutes: Physiological Basis of Efficacy, Winslow, et al. Birkhauser. 1995; 143–154
- Tsai A., Kerger H., Intaglietta M. Microcirculatory consequences of blood substitution with αα-hemoglobin. Blood substitutes: Physiological Basis of Efficacy, R. Winslow, K. Vandegriff, M. Intaglietta. Birkhauser. 1995; 155–174
- Alayash A. Effects of intra- and intermolecular crosslinking on the free radical reactions of bovine hemoglobins. Free Rad Biol Med 1995; 18: 295–301
- Rogers M., Ryan B., Cashon R., Alayash A. Effects on polyermization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin. Biochem Biophys Acta 1995; 38: 135–142
- Linberg R., Conover C., Shum K., Shorr R. Hemoglobin based oxygen carriers: How much methemoglobin is too much?. Art. Cells, Blood Subs., and Immob. Biotech., In press